MDMA-assisted Acceptance and Commitment Therapy for Posttraumatic Stress Disorder: Rationale for a New Approach
Mathew Herbert, Brian H. Blanco, Dimitri Perivoliotis, Jason B. Luoma, Gisele Fernandes-Osterhold, Andrew W. Bismark, Joshua Woolley
September 7, 2025 preprint DOI: 10.31234/osf.io/7xyfq_v1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper |
|---|---|
| Interventions | MDMA-assisted psychotherapy Acceptance and Commitment Therapy |
| Topics | MDMA PTSD |
| Keywords | Standardization Posttraumatic stress Cognition Psychotherapist Quality philosophy Cognitive behavioral therapy Empirical research Clinical psychology |
| Key points | Proposes that Acceptance and Commitment Therapy is well-suited to be integrated with MDMA for treating PTSD, providing a structured, evidence-based framework. |
Abstract
There is promise for 3,4-Methylenedioxymethamphetamine (MDMA)-assistedpsychotherapy as a highly effective and durable treatment for posttraumatic stress disorder(PTSD). However, the Food and Drug Administration rejected MDMA-assisted psychotherapy inits current form, expressing concerns about the lack of standardization and empirical basis ofpsychotherapy methods. This highlights the need to consider alternative psychotherapeuticapproaches to integrate with MDMA for the treatment of PTSD. We propose that the evidencebased cognitive behavioral therapy, Acceptance and Commitment Therapy (ACT), is particularlywell-suited to be paired with the administration of MDMA for PTSD. Specifically: 1) thesubjective effects of MDMA directly support key ACT processes; 2) ACT methods could helpprepare patients for MDMA administration, increasingly the likelihood of efficacy andtolerability; 3) ACT provides a “process-directed” approach to assist the therapist and help thepatient during MDMA administration sessions; and 4) ACT may help optimize the integration ofMDMA experiences to shape adaptive functioning and promote quality of life followingtreatment. We provide examples of how ACT methods could be used for many of these goals. Insum, we believe ACT provides a highly scalable, structured yet flexible, evidence-basedframework well-suited to be integrated with MDMA as a new treatment approach for PTSD.
Comparable studies
Other theoretical and historical papers on MDMA for PTSD, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD. | 2021 | Theoretical or philosophical paper | |
| MDMA-assisted psychotherapy for PTSD in adolescents: rationale, potential, risks, and considerations. Adolescents with PTSD | 2024 | Theoretical or philosophical paper | |
| Incorporating MDMA as an Adjunct in Emotionally Focused Couples Therapy With Clients Impacted by Trauma or PTSD | 2019 | Theoretical or philosophical paper | |
| MDMA-assisted therapy: challenges, clinical trials, and the future of MDMA in treating behavioral disorders. | 2025 | Theoretical or philosophical paper | |
| Development of an Australian Clinical Practice Guideline on methylenedioxymethamphetamine (MDMA)-assisted Psychotherapy for Post-traumatic Stress Disorder. People with post-traumatic stress disorder | 2025 | Theoretical or philosophical paper |